Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
The Lancet. Infectious Diseases
|
September 19, 2025
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial
Selidji T Agnandji, Jeroen Bok, Ayodele Alabi, et al.
The Journal of Infectious Diseases
|
December 13, 2024
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines
Gregory J Wilson, L W Preston Church, Colleen F Kelley, et al.
Malaria Journal
|
March 18, 2025
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
Andrea A Berry, Thomas L Richie, L W Preston Church, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
April 8, 2022
The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
Stephen R Manock, Vicente Urbano Nsue, Ally Olotu, et al.
The Journal of Infectious Diseases
|
April 4, 2002
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
Stephen L Hoffman, Lucy M L Goh, Thomas C Luke, et al.
Journal of Travel Medicine
|
January 11, 2024
Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics
Eric R James, L W Preston Church, Stephen L Hoffman, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 25, 2020
Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea
Stephen R Manock, Ali Mtoro, Vicente Urbano Nsue Ndong, et al.
Ebiomedicine
|
October 1, 2024
PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults
Anneth Tumbo, Freia-Raphaella Lorenz, Annie S P Yang, et al.
NPJ Vaccines
|
August 23, 2022
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
Benjamin Mordmüller, Zita Sulyok, Mihály Sulyok, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2019
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya
Laura C Steinhardt, Thomas L Richie, Reuben Yego, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
The Lancet. Infectious Diseases
|
September 19, 2025
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial
Selidji T Agnandji, Jeroen Bok, Ayodele Alabi, et al.
The Journal of Infectious Diseases
|
December 13, 2024
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines
Gregory J Wilson, L W Preston Church, Colleen F Kelley, et al.
Malaria Journal
|
March 18, 2025
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
Andrea A Berry, Thomas L Richie, L W Preston Church, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
April 8, 2022
The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
Stephen R Manock, Vicente Urbano Nsue, Ally Olotu, et al.
The Journal of Infectious Diseases
|
April 4, 2002
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
Stephen L Hoffman, Lucy M L Goh, Thomas C Luke, et al.
Journal of Travel Medicine
|
January 11, 2024
Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics
Eric R James, L W Preston Church, Stephen L Hoffman, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 25, 2020
Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea
Stephen R Manock, Ali Mtoro, Vicente Urbano Nsue Ndong, et al.
Ebiomedicine
|
October 1, 2024
PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults
Anneth Tumbo, Freia-Raphaella Lorenz, Annie S P Yang, et al.
NPJ Vaccines
|
August 23, 2022
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
Benjamin Mordmüller, Zita Sulyok, Mihály Sulyok, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2019
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya
Laura C Steinhardt, Thomas L Richie, Reuben Yego, et al.
Page
of 4